PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
NCT00236275
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Fluoro-L-thymidine-(18F)
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]